Medicana Health Group extends its patient-centered service chain with a second Bone Marrow Transplantation Center, bringing hope to cancer patients now in Istanbul after Ankara. Providing treatment for more than 2 million patients annually with 30 years of track record in the Turkish healthcare sector, Medicana Health Group has opened its brand new Bone Marrow Transplantation Center in Istanbul, for treatment of malignant blood diseases such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome.
The center brings together a very sophisticated technology with an experienced team of specialists to create a perfect holistic treatment concept for each patient who requires bone marrow transplantation. Medicana Health Group, with its cutting-edge technology, distinguished academic medical professionals, patient-centered services and advanced health care in every branch of medicine, now offers a breath of fresh air for Istanbul with its second Bone Marrow Transplantation Center following the one in Medicana International Ankara. We are very proud to announce that our new Bone Marrow Transplantation Center is going to be managed by a strong, academical medical team of specialists under the leadership of Haematology and Medical Oncology Specialist Professor Yener Koç in İstanbul Beylikdüzü.
Already a Leader in Organ Transplantation, Medicana Health Group Aims for International Success in Bone Marrow Transplantation
Internationally renowned for its success in the field of Organ Transplantation, Medicana Health Group, in line with its vision to be “The Reference Center in many departments” in Turkey, has been serving patients in Medicana Bone Marrow Transplantation Center. Following the first Bone Marrow Center in Ankara, the new center will be able to meet the bone marrow needs of not only local patients but also patients from all corners of the world.
Patients will be offered a Holistic Service Approach
Within a framework of international standards for bone marrow transplantation; patients will be treated holistically, addressing all their health needs. The Center, equipped with a modern Transplantation Immunology Laboratory, will be able to provide bone marrow transplantation for patients with blood disorders such as Multiple Myeloma (malignant bone marrow disorder originating from plasma cells), lymphoma (hematologic lymph node cancer), acute leukemia and chronic leukemia as well as aplastic anemia.
An Internationally Distinguished Team in Bone Marrow Transplantation
The bone marrow transplantation center of Medicana International Istanbul Hospital will be led by Prof. Yener Koç, M.D. who has a distinguished career in bone marrow transplantation and stem cell therapies.
Professor Yener Koç, M.D., has authored 225 papers that have been cited for 2579 times and he is also a peer reviewer in both local and international hematology and oncology journals.
Being awarded the “Doctor of the Year” by Boston University twice in 1995 and 1996, Prof. Yener Koç, M.D., has been granted a special visa (for individuals with extraordinary ability or achievement) by the U.S. government in 1997 and he has been working actively for the Joint Accreditation Committee ISCT-Europe & EBMT (JACIE) since 2004 in his capacity as a European Bone Marrow Accreditation Inspector. Prof. Yener Koç, M.D., who was awarded the “International Bone Marrow Transplant Professional of The Year” in 2007, was also listed in Who’s Who Science and Engineering Encyclopedia, where distinguished scientists in the world are introduced, in 2016.
He is a member of American Society of Hematology (ASH), American Society for Blood and Marrow Transplantation (ASBMT), and European Society for Blood and Marrow Transplantation (EBMT).
About Medicana Group
Meeting the healthcare needs of patients since 1992, Medicana Group operates with 12 hospitals located in Istanbul, Ankara, Konya, Samsun, Sivas, and Bursa. Providing patients with the state-of-the-art means of medicine by 7,000 employees, Medicana Group maintains its pioneering position in the private healthcare sector through more than 2,000,000 outpatient admissions and 385,000 hospitalizations per year.
Medicana Group has founded the Medicana Education Group and started up the MBA (Medicana Sciences Academy) based on the approach of “holistic education for each person” in the academic year of 2018-2019. Currently, the Group makes the best effort to be the leading educational organization of Turkey in all value chains of the education in three schools, namely Göztepe and Beylikdüzü Campuses in Istanbul and Eryaman Campus in Ankara.
Medicana Education Group has founded the Fenerbahçe University in the academic year of 2019-2020, investing in higher education in Turkey.